Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The dose of this medicine should be determined based on each patient’s current treatment, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be adjusted gradually to reduce gastrointestinal adverse reactions associated with metformin.
Take one 20/1000mg extended-release tablet once daily.
Patients taking the 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily.
For patients who are unable to achieve adequate glycemic control with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient’s current metformin dose. For patients switching to this medicine from concomitant therapy with teneligliptin and metformin, treatment may be started at the doses of teneligliptin and metformin they were previously taking. When switching from immediate-release metformin to an extended-release formulation, glycemic control should be closely monitored and the dose adjusted appropriately. When administered with a sulfonylurea, a reduction in the dose of the sulfonylurea may be considered to reduce the risk of hypoglycemia.
The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg.
The safety and efficacy of this medicine have not been specifically evaluated in patients switching from other glucose-lowering medicines. Because any change may affect glycemic control, all changes in the treatment of patients with type 2 diabetes should be made under careful monitoring.
To maintain the extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.
Improvement of glycemic control in patients with type 2 diabetes mellitus
View approved original textHide original text
This medication is used to improve blood sugar control in patients with type 2 diabetes. By taking Teneligliptin and Metformin together, it enhances the effects of dietary and exercise therapies, helping patients manage their blood sugar more effectively. Thus, this medication plays a significant role in improving blood sugar control.
How to take
Adult dose
The dose of this medicine should be determined based on each patient’s current treatment, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be adjusted gradually to reduce gastrointestinal adverse reactions associated with metformin.
Take one 20/1000mg extended-release tablet once daily.
Patients taking the 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily.
For patients who are unable to achieve adequate glycemic control with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient’s current metformin dose. For patients switching to this medicine from concomitant therapy with teneligliptin and metformin, treatment may be started at the doses of teneligliptin and metformin they were previously taking. When switching from immediate-release metformin to an extended-release formulation, glycemic control should be closely monitored and the dose adjusted appropriately. When administered with a sulfonylurea, a reduction in the dose of the sulfonylurea may be considered to reduce the risk of hypoglycemia.
The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg.
The safety and efficacy of this medicine have not been specifically evaluated in patients switching from other glucose-lowering medicines. Because any change may affect glycemic control, all changes in the treatment of patients with type 2 diabetes should be made under careful monitoring.
To maintain the extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.
Precautions
This medication is primarily used for the treatment of diabetes and contains two active ingredients.
First, it should only be given to patients with normal kidney function and should not be used in patients with moderate to severe renal impairment.
Second, it should not be administered in cases where kidney function is rapidly deteriorating due to severe heart failure, acute myocardial infarction, sepsis, etc.
Third, this medication should be discontinued before examinations that use radiographic iodine contrast and should be resumed only after confirming normal kidney function post-examination.
Fourth, it is not to be used in patients with type 1 diabetes or those with metabolic acidosis such as lactic acidosis or diabetic ketoacidosis.
Fifth, it should not be administered to individuals with allergies to its ingredients.
Sixth, in patients with severe infections, serious trauma, preoperative or postoperative conditions, malnutrition, liver dysfunction, lung impairment, excessive alcohol intake, etc., the administration should be temporarily withheld or used cautiously.
Seventh, this medication may cause hypoglycemia, so caution is needed for hypoglycemic symptoms when used in conjunction with insulin or other hypoglycemic agents.
Eighth, if symptoms such as abdominal pain, vomiting, or constipation persist, there may be a risk of pancreatitis or gastrointestinal disorders, and consultation with a physician is advisable.
Ninth, it is generally recommended that pregnant women, women with potential for pregnancy, and nursing mothers do not use this medication.
Tenth, the elderly may have diminished kidney function, thus requiring regular monitoring of kidney function and possible dosage adjustment.
Lastly, during treatment with this medication, alcohol consumption should be avoided, and if symptoms of lactic acidosis or hypoglycemia (fatigue, muscle pain, difficulty breathing, weakness, abdominal pain, cold sweat, trembling, confusion, etc.) occur, a physician should be notified immediately.
Side effects
Severe lactic acidosis
severe hypoglycemia
hypoglycemia
constipation
intestinal obstruction
liver dysfunction
interstitial pneumonia
dermatomyositis
acute pancreatitis
dizziness
Show 160 moreCollapse
abdominal distension
abdominal discomfort
nausea
abdominal pain
bloating
stomatitis
gastric polyp
colon polyp
duodenal ulcer
gastroesophageal reflux disease
diarrhea
loss of appetite
elevated amylase
elevated lipase
increased AST (GOT)
increased ALT (GPT)
elevated GGT
increased ALP
proteinuria
ketonuria
potential hematuria
eczema
rash
itching
allergic dermatitis
arthralgia
elevated CK (CPK)
increased serum potassium levels
lethargy
allergic rhinitis
elevated serum uric acid
peripheral edema
shingles
limb pain
upper abdominal pain
gastritis
upper respiratory tract infection
tremors
headache
weakness
hunger
fatigue
facial edema
dyspepsia
nausea
viral upper respiratory tract infection
rhinitis
sweating
diabetic retinopathy
vision impairment
cough
pulmonary congestion
shortness of breath
drug overdose
benign prostatic hyperplasia
headache
diarrhea
chronic gastritis
irritable bowel syndrome
fatigue
cerebral infarction
hyperglycemia
liver biopsy
decreased neutrophils
abnormal blood sugar
increased blood sugar
increased blood pressure
hepatic coma
lumbar spinal canal stenosis
intervertebral disc protrusion
intervertebral disc disorder
spinal ligament ossification
foraminal stenosis
rotator cuff syndrome
cataract
depression
iliac artery stenosis
vertigo
benign prostatic hyperplasia
knee surgery
urticaria
hepatic coma
sensory disturbance
sensory loss
tension headache
peripheral neuropathy
facial paralysis
sciatica
positional dizziness
muscle weakness
low back pain
limb pain
lumbar spinal canal stenosis
tendonitis
cervical pain
bone pain
osteoarthritis
osteoporosis
muscle spasm
foot deformity
hypertrophic osteoarthropathy
bursitis
spinal osteoarthritis
intervertebral disc protrusion
intervertebral disc disorder
spinal ligament ossification
foraminal stenosis
postmenopausal osteoporosis
rotator cuff syndrome
gastroenteritis
influenza
uterine abscess
subcutaneous abscess
vomiting
chronic gastritis
upper abdominal pain
mouth sores
esophagitis
gastrointestinal motility disorder
reduced gastrointestinal motility
enteritis
toothache
anal rectal discomfort
acquired mixed hyperlipidemia
hypertriglyceridemia
vitamin D deficiency
abnormal weight gain
essential hypertension
orthostatic hypotension
white coat hypertension
bleeding
increased blood sugar
abnormal sputum
toxic hepatitis
chronic cholecystitis
non-alcoholic fatty liver disease
alcoholic liver disease
eyelid injury
ligament sprain
lip injury
bruise
glaucoma
blurred vision
age-related macular degeneration
hyperthyroidism
hyperparathyroidism
coronary artery disease
unstable angina
angina pectoris
otalgia
iron deficiency anemia
food allergy
pressure ulcer
hearing loss
endolymphatic hydrops
ovarian cyst
vulvar pruritus
menopausal symptoms
anemia
atrial fibrillation
Not everyone experiences these, and they can vary from person to person.
Storage
This medication should be stored in a tightly sealed container to prevent air exposure, and it is best kept at room temperature between 1 to 30 degrees Celsius. Storing it this way helps maintain the medicine's efficacy.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
Questions about this medicine
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety. Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.